RxDoctor Payments Data

Rachel Maynard

Psychiatric/Mental Health · Louisa, KYNPI 1093467052

Payments from drug & device makers

$3,771in general payments, 2019–2025

Across 225 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$610
  • AbbVie$480
  • Otsuka America Pharmaceutical, Inc.$475
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$453
  • Alkermes, Inc.$441
  • Johnson & Johnson$314
  • plus $998 from 9 others

What the payments were for

  • Food & beverage$3,46692%
  • Education$3058%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,771 in reported general payments places this provider in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$6,265
Medicare patients
28
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine26$126,790
VraylarCariprazine Hcl71$103,557
RexultiBrexpiprazole11$18,616
Aripiprazole136$4,481
Quetiapine Fumarate162$3,207
Vilazodone Hcl33$3,098
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl23$3,001
Desvenlafaxine Succinate ErDesvenlafaxine Succinate83$2,638
Duloxetine Hcl92$1,999
Trazodone Hcl175$1,942
Olanzapine44$1,502
Sertraline Hcl73$1,114
Hydroxyzine Hcl100$998
Buspirone Hcl96$737
Risperidone66$656

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$610$126,79026 claims
AbbVieVraylar$480$103,55771 claims
Otsuka America Pharmaceutical, Inc.Rexulti$475$18,61611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Louisa

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →